Company updateBusinessLine
Broker’s Call: Healthcare Global Enterprises (Buy)
Positive+5
GreyOak summary
The company reported 16% revenue growth and an EBITDA margin expansion to 19.7%. Management guides for mid-teens revenue growth and high-teens EBITDA expansion.
What it affects
- Healthcare Global EnterprisesHCGPositive +5
Revenue grew 16% with strong EBITDA margin expansion.Rolling sentiment Negative -19
Source
Read the original at BusinessLineMore Healthcare Global Enterprises news
- Buy HealthCare Global Enterprises: target of Rs 700: ICICI SecuritiesMoneycontrol · Company update ·
- HCG Q2 profit slips 9% despite strong revenue growthMoneycontrol · Results ·
- Healthcare Global Enterprises Q2 net profit declines 55%BusinessLine · Results ·